Twonewnucleotide antibiotics, fosfadecin and fosfocytocin, have been isolated from the culture filtrates of Pseudomonas viridiflava PK-5and Pseudomonasfluorescens PK-52, respectively. These antibiotics werepurified by columnchromatographies using adsorption, gel filtration and ion exchange resins. Onthe basis of the spectroscopic and degradation studies, the chemical structures of fosfadecin and fosfocytocin were determined. These antibiotics were either enzymatically or chemically hydrolyzed to generate fosfomycin and a new antibiotic, fosfoxacin, which are also produced in the culture filtrates. They showed antibacterial activity against Gram-positive and Gram-negative bacteria. The antibacterial activity of these nucleotide antibiotics was weaker than that of fosfomycin and fosfoxacin.
strain PK-52 was identified as P. fluorescens and designated P. fluorescens PK-52. P. viridiflava PK-5 and P. fluorescens PK-52 have been deposited in the Institute for Fermentation, Osaka and have the accession No. IFO 14515 and IFO 14676, respectively.
Fermentation
Fosfadecin (1) and Fosfomycin (3)
A loopful of P. viridiflava PK-5 cells which had been grown on nutrient agar was inoculated into a 2-liter Sakaguchi flask containing 500ml of seed medium consisting of glucose 2%, soluble starch 3%, corn steep liquor 0.3%, Polypepton (Nihon Pharmaceutical Co., Ltd.) 0.5%, NaCl 0.3%, CaCO3 0.5%, (pH 7.0). The cultivation was carried out at 24°C for 48 hours on a reciprocal shaker. The seed culture thus obtained was transferred to a 50-liter fermenter containing 30 liters of the same seed medium Table 1 . Morphological and physiological characteristics of strains PK-5 and PK-52. MAR. 1990 Characteristic PK-5 PK-52 Characteristic PK-5 PK-52 Fosfocytocin (2) and Fosfoxacin (4) P. fluorescens PK-52 was cultivated in the same manner as that described for fosfadecin, except that the fermentation medium consisted of sucrose 3%, corn steep liquor 1.5%, dried yeast 1.5%, and Actcol 0.05% (pH 6.5). Fosfocytocin was detected from the early stage to the end of fermentation, while fosfoxacin was produced in later stage. Unlike fosfomycin, fosfoxacin did not accumulate to a great extent. The titer of fosfocytocin plus fosfoxacin calculated as fosfocytocin was about 60 fig/ml.
Isolation
Fosfadecin (1) The culture broth of strain PK-5 was filtered through Hyflo-Super Cel. The filtrate (98 liters) was applied to a columnof Amberlite IRA-402 (Cl~type, 5 liters), and the active substance was eluted with 1 m NaCl (50 liters). The eluate was subjected to activated carbon chromatography (4 liters) eluting with 8%isobutyl alcohol -0.02m ammonia (16 liters). The eluate was concentrated and chromatographed on QAE-Sephadex A-25 (Cl~type, 3 liters) eluting with 0.1 m NaCl. The active fractions were combined and subjected to activated carbon chromatography (0.8 liters) eluting with 8% isobutyl alcohol. The eluate was concentrated and again chromatographed on QAE-Sephadex A-25 (Cl~type, 1 liter), this time eluting with 0.09 m NaCl. The active fractions were desalted with activated carbon (150ml), concentrated and freeze-dried to give a white powder of fosfadecin as the disodium salt (1.46 g).
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The culture broth of strain PK-5 was centrifuged and the supernatant (700 ml) was chromatographed on a column of Dowex 1X2 (50-100 mesh, Cl" type, 35ml) eluting with 2% NaCl. After being adjusted to pH 5, the eluate was purified by alumina chromatography (20 ml). The mediumwas washed with water, 75%methanol and 75%methanol -1 m ammonia, and active substance was finally eluted with 1 m ammonia water. The eluate was concentrated and methanol (60 ml) was added to the concentrate (6 ml). The mixture was filtered and the insoluble material was discarded. The filtrate was concentrated and freeze-dried to give a crude powder of fosfomycin (195 mg, purity 5%).
Fosfocytocin (2) The culture broth of strain PK-52 was filtered through Hyflo-Super Cel. The filtrate (100 liters) was applied to a column of Amberlite IRA-402(Cl~type, 7 liters), and the active substance was eluted with 1 mNaCl (30 liters). The eluate was subjected to activated carbon chromatography (10 liters) eluting with 8% isobutyl alcohol (50 liters). The eluate was concentrated and chromatographed on Amberlite IRA-68 (Cl~type, 2 liters) eluting with 1 m NaCl. The active fractions were desalted with activated carbon (2 liters) and concentrated. The concentrate was chromatographed on QAE-Sephadex A-25 (Cl~type, 2.2 liters) eluting with 0. 1 mNaCl. The active fractions were desalted with activated carbon, concentrated and freeze-dried to give a crude powder offosfocytocin (1.72 g). The powder (870 mg) was purified by preparative HPLCusing a YMC-PackSH-343 (Yamamura Chem. Lab.) with a mobile phase of 0.02m phosphate buffer (pH 6.3). The pure fractions were desalted with activated carbon, concentrated and freeze-dried to give a white powder of fosfocytocin as the disodium salt (295mg).
Fosfoxacin (4)
The culture broth of strain PK-52 was centrifuged and the supernatant (1.5 liters) was passed through a column of activated carbon (150ml). The effluent was chromatographed on a column of Dowex1X2 (50-100 mesh, Cl" type, 150ml) eluting with 1 m NaCl. After being adjusted to pH2.0, the eluate was chromatographed on a column of activated carbon (150 ml) eluting with water. The active fractions were concentrated and adjusted to pH 2.0. The concentrate was again chromatographed on activated carbon (100 ml), this time eluting with 8%isobutyl alcohol. The active fractions were concentrated and freeze-dried to give a crude powder of fosfoxacin (47mg, purity 3%).
Physico-chemical Properties
The physico-chemical properties of fosfadecin (1), fosfocytocin (2) and fosfoxacin (4) are summarized in Table 2 . They are soluble in water and dimethyl sulfoxide, and sparingly soluble in acetone and ethyl acetate. The molecular formulae of 1, 2 and 4 were determined based on the elemental analyses, the molecular ion peaks in the SI-MS and the carbon numbers in the 13C NMRspectra. The UVabsorption spectra suggested 1 had an adenine chromophore and 2 had a cytosine chromophore. Compounds1, 2 and 4 showed a positive color reaction to molybdate reagent suggesting the presence of a phosphoric acid function. Furthermore, compounds2 and 4 showed a positive color reaction to ferric chloride suggesting the presence of a hydroxyamide moiety.
Structural Determination
The 13C, *H and 31P NMRdata are summarized in Tables 3 and 4 . When 1 was hydrolyzed in 1n sodium hydroxide, adenosine 5'-monophosphate (5) and fosfomycin (3) were obtained as shown in Fig.  1 . In the 31P NMRspectrum of 1, two signals coupled with each other. This data showed that 3 and 5 were bound by a phosphate bond. Upon enzymatic hydrolysis, 2 gave cytidine 5'-monophosphate (6) and 4. And the same as with 1, signals coupled in the 31P NMRspectrum of 2. Therefore 4 and 6 are bound by a phosphate bond. The 1H NMRspectrum of4 showed a formyl proton at 7.97 and 8.35 ppm and two methylene protons at 3.76 and 4.04ppm. In the 13C NMRspectrum of 4, each signal was observed as a pair. This was explained by the existence of conformational isomers of the formyl amide moiety. Furthermore, in the proton decoupled 13C NMRspectrum, two methylene signals coupled with phosphorus (/= 5. 1 and 7.0 Hz). Fromall these results, the structure of 4 was determined to be 2-(7V-formyl-A^-hydroxy)aminoethyl phosphoric acid.
Biological Activity
The antibacterial activity of fosfadecin, fosfomycin, fosfocytocin and fosfoxacin is shown in Table 5 . Fosfadecin was more active against the fosfomycin-sensitive mutants (EF-7, PF-4) than against their parents (LD-2, IFO 3080). Fosfocytocin and fosfoxacin showed higher antibacterial activity against the fosmidomycin2)-sensitive mutant (NCWP)than against the parent (NCW). Fosfoxacin exhibited potent antibacterial activity against Bacillus cereus, Micrococcus luteus, Pseudomonas aeruginosa and Aeromonas caviae.
The nucleotide antibiotics, fosfadecin and fosfocytocin, showed weaker antibacterial activity than fosfomycin and fosfoxacin, which do not have the nucleotide moiety.
All of these antibiotics induced spheroplast formation in Gram-negative bacteria in a hypertonic medium(data not shown), suggesting that they inhibit biosynthesis of bacterial cell wall.
Fosfadecin was effective in mice against experimental infection with Staphylococcus aureus and Table 3 . 13C and^NMRspectral data of fosfadecin (1), fosfocytocin (2) and fosfoxacin (4) The S values were recorded in ppm down field from 3-(trimethylsilyl)propionic acid-d4 sodium salt using a Bruker m: Multiplicity. Coupling constants are given in Hz.
Escherichia coli. The ED50 value is shown in Table  6 . Fosfocytocin and fosfoxacin were not effective in experimental therapy.
Discussion
During the search for new antibiotics which inhibit bacterial cell wall biosynthesis, biological activity similar to that of fosfomycin was detected in the culture filtrate of bacteria. The active principle was identified as fosfomycin and new antibiotics fosfadecin, fosfocytocin and fosfoxacin. It has been reported that P. syringae PB-5123 produces fosfomycin in its culture filtrate3). P. viridiflava PK-5 seems to differ from P. syringae PB-5123, because the latter has multitricous flagella and produces arginine dihydrolase.
The structure of fosfadecin was confirmed to be a combination of the structures of fosfomycin and MICs were determined by the microtiter plate method using Bacto-Nutrient Broth (Difco) containing 0.002% diaminopimelic acid.
Final inoculum size was 105 cfu/ml. a Figures in parentheses mean MAC(jug/ml), maximumallowance concentrations of growth.
E. coli EF-7: Fosfomycin-sensitive mutant derived from LD-2. P. aeruginosa PF-4: fosfomycin-sensitive mutant derived from IFO 3080. A. caviae NCWP:fosmidomycin-sensitive mutant derived from NCW.A. caviae NCWO: fosmidomycin-resistant mutant derived from NCW. NT: Not tested. adenosine 5'-monophosphate.
Fosfocytocin was determined to have the structure of cytidylated fo sfoxacin.
In the time course of fermentation using strain PK-5, fosfadecin was detected from the early stage to the end of fermentation, while fosfomycin was produced only in the later stage. Fosfadecin seems to be an intermediate in fosfomycin biosynthesis. However, only two of the 12 strains which we isolated as fosfomycin producers, produced fosfadecin, and we have not yet succeeded in converting a strain which produces only fosfomycin into a fosfadecin producing strain. Therefore, fosfadecin maynot be a commonintermediate in fosfomycin biosynthesis but may be a shunt product. This remains to be solved. Mice were infected intraperitoneally with 0.5 ml of a suspension of bacteria (108 cfu/ml). Groups of five mice at each dose level were given 0.2ml of an antibiotic solution immediately after infection.
The ED50 was calculated from the survival rate at 5 days after infection.
These nucleotidyl compounds showed decreased antibacterial activity. Although nucleotidylation makes the MWof the compound only about three times as high, the antibacterial activity is drastically decreased. This points to the possibility of fosfadecin and fosfocytocin's being inactivated compounds of fosfomycin and fosfoxacin.
In clinical isolates which are resistant to aminoglycoside antibiotics such as streptomycin40, kanamycin5) and gentamicin6), it is well known that the inactivation of these antibiotics by nucleotidylation is one of the mechanismsof drug resistance. It is possible that the nucleotide antibiotics, fosfadecin and fosfocytocin, which have decreased antibacterial activity, are the inactivated products of fosfomycin and fosfoxacin which are inactivated by the producing bacteria for detoxication. On the other hand, nucleotides act physiologically not only as building blocks for nucleic acid synthesis but also as metabolite carriers, energy donors, second messengers, and co factors for various enzymes. Therefore, it will be interesting to determine the physiological role of these nucleotide antibiotics.
Experimental
Hydrolysis of Fosfadecin (1) A solution of the disodium salt of fosfadecin (500mg) in 1 n NaOH (50ml) was stirred for 10 hours at 50°C and was then allowed to stand for 15 hours at room temperature. The reaction mixture was adjusted to pH 7 and subjected to activated carbon chromatography (60 ml) with an elution of 8%isobutyl alcohol -0.02m ammonia. The eluate was chromatographed on Dowex 50WX2(H+ type, 50~100 mesh, 20 ml) eluting with 0. 1 mformic acid. The eluate was evaporated to dryness, and the residue was crystallized from water-acetone to give adenosine 5 '-monophosphate (190mg The other spectral data were identical to those of the authentic sample. The effluent in the process of the activated carbon chromatography was applied to a column of alumina (60 ml) and eluted with 1 Mammonia water. The eluate was concentrated and applied to a column of Dowex 50WX2(Na+ type, 50~100 mesh, 15 ml). The concentrate of the effluent was chromatographed on Bio-Gel P-2 (100~200 mesh, 200ml) eluting with water. The pure fractions were concentrated and freeze-dried to give a powder of fosfomycin as the disodium salt (126mg The other spectral data were identical to those of the authentic sample.
Hydrolysis of Fosfocytocin (2)
To the solution of the disodium salt offosfocytocin (500 mg) in 0.05 m Tris-HCl buffer (pH 7.4, 300 ml), MgCl2 (258 mg) and nucleotide pyrophosphatase (150u, snake venom, Sigma) were added and the mixture was incubated at 37°C for 100 minutes. The reaction mixture (300 ml) was chromatographed on a columnof activated carbon (30ml) using 70% acetonitrile-0.02m ammonia as the eluent. The eluate was chromatographed on Dowex 50WX2 (H+ type, 50~100 mesh, 20ml) eluting with 0.1 M formic acid. The eluate was evaporated to dryness, and the residue was crystallized from water-acetone to give cytidine 5'-monophosphate (217 mg). The physico-chemical data were identical to those of the authentic sample.
The effluent in the process of the activated carbon chromatography was applied to a column of QAE-Sephadex A-25 (Cl~type, 100ml) and eluted with 0.02 and 0.05m NaCl. The active fractions were concentrated, applied to a column of Bio-Gel P-2 (100~200 mesh, 500ml) and eluted with water. The active fractions were concentrated and again chromatographed on Bio-Gel P-2 (100~200 mesh, 500ml) eluting with water. The pure fractions were concentrated and freeze-dried to give a white powder of fosfoxacin as the monosodiumsalt (76 mg).
